NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080225165

Registered date:20/04/2020

Basic Information

Recruitment status recruiting
Health condition(s) or Problem(s) studied
Date of first enrollment18/08/2020
Target sample size600
Countries of recruitmentJapan,Asia except Japan,North America,South America,Europe
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : INN of investigational material : pembrolizumab, cisplatin, 5-FU, leucovorin, levoleucovorin, oxaliplatin Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - , cisplatin, 5-FU, leucovorin, levoleucovorin, oxaliplatin Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcomeefficacy
Secondary Outcomesafety

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteria
Exclude criteria

Related Information

Contact

Public contact
Name
Address
Telephone -
E-mail JPCT@merck.com
Affiliation
Scientific contact
Name
Address
Telephone -
E-mail JPCT@merck.com
Affiliation